10A1 MuLV induces a murine leukemia that expresses hematopoietic stem cell markers by a mechanism that includes fli-1 integration
- PMID: 7975258
- DOI: 10.1006/viro.1994.1680
10A1 MuLV induces a murine leukemia that expresses hematopoietic stem cell markers by a mechanism that includes fli-1 integration
Abstract
The 10A1 murine leukemia virus induces tumors that lack lineage-specific markers found on myeloid, T-cell, and B-cell lineages. Either erythroid or multipotent stem cells can have this phenotype; therefore we have used fluorescence-activated cell sorter analysis with either multipotent stem cell markers or markers found on lineage-restricted precursors to differentiate between these two possibilities. The results showed that tumors induced by 10A1 expressed multipotent stem cell markers as well as some lineage-restricted precursor markers. To further study the tumor phenotype, we analyzed total RNAs from 10A1-induced tumors by Northern blotting for c-kit, erythropoietin receptor, and T-cell gamma receptor mRNAs. Most of the tumors contained these mRNAs, which are characteristic of early hematopoietic cells. These results are consistent with the hypothesis that 10A1-induced tumor cells are early multipotent hematopoietic stem cells. Southern blot analysis revealed that 14 of 14 10A1-induced tumor cell DNAs examined contained MuLV integrations into the fli-1 gene. The results strongly suggested that promoter insertion into fli-1 is required for tumor formation.
Similar articles
-
Importance of receptor usage, Fli1 activation, and mouse strain for the stem cell specificity of 10A1 murine leukemia virus leukemogenicity.J Virol. 2007 Jan;81(2):732-42. doi: 10.1128/JVI.01430-06. Epub 2006 Nov 1. J Virol. 2007. PMID: 17079317 Free PMC article.
-
Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice.Virology. 2000 Mar 15;268(2):308-18. doi: 10.1006/viro.2000.0183. Virology. 2000. PMID: 10704339
-
The Fli-1 proto-oncogene, involved in erythroleukemia and Ewing's sarcoma, encodes a transcriptional activator with DNA-binding specificities distinct from other Ets family members.Oncogene. 1993 Jun;8(6):1621-30. Oncogene. 1993. PMID: 8502483
-
Ets and retroviruses - transduction and activation of members of the Ets oncogene family in viral oncogenesis.Oncogene. 2000 Dec 18;19(55):6472-81. doi: 10.1038/sj.onc.1204046. Oncogene. 2000. PMID: 11175363 Review.
-
Genetic heterogeneity in acute myeloid leukemia: maximizing information flow from MuLV mutagenesis studies.Leukemia. 2000 Jul;14(7):1174-84. doi: 10.1038/sj.leu.2401852. Leukemia. 2000. PMID: 10914539 Review.
Cited by
-
The ets transcription factor Fli-1 in development, cancer and disease.Oncogene. 2015 Apr 16;34(16):2022-31. doi: 10.1038/onc.2014.162. Epub 2014 Jun 9. Oncogene. 2015. PMID: 24909161 Free PMC article. Review.
-
Defective megakaryopoiesis and abnormal erythroid development in Fli-1 gene-targeted mice.Int J Hematol. 2001 Jun;73(4):463-468. doi: 10.1007/BF02994008. Int J Hematol. 2001. PMID: 11503960
-
Importance of receptor usage, Fli1 activation, and mouse strain for the stem cell specificity of 10A1 murine leukemia virus leukemogenicity.J Virol. 2007 Jan;81(2):732-42. doi: 10.1128/JVI.01430-06. Epub 2006 Nov 1. J Virol. 2007. PMID: 17079317 Free PMC article.
-
Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor.Mol Cell Biol. 2000 Aug;20(15):5643-52. doi: 10.1128/MCB.20.15.5643-5652.2000. Mol Cell Biol. 2000. PMID: 10891501 Free PMC article.
-
EWS/FLI-1 induces rapid onset of myeloid/erythroid leukemia in mice.Mol Cell Biol. 2007 Nov;27(22):7918-34. doi: 10.1128/MCB.00099-07. Epub 2007 Sep 17. Mol Cell Biol. 2007. PMID: 17875932 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Medical